IL1B and Hyperammonemia: Bicuculline treatment did not alter the IL-1β content in control rats but significantly reversed the increase in hyperammonemic rats (97 ± 9% of controls, p < 0.01 compared with hyperammonemia without bicuculline) (F (3, 46) = 8.695), p < 0.0001) (Figure 4e).